Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
August 2013, Vol 6 ADA 2013 Highlights
Emerging Therapies
GLP-1 Agonists May Protect Patients with Diabetes from Heart Failure
Wayne Kuznar
Read More
Highlights from the ADA President’s Research Sessions
Mary Mosley
Read More
Look AHEAD: Lifestyle Intervention Cost-Effective in Overweight Patients with Type 2 Diabetes
Wayne Kuznar
Read More
Emerging Therapies
SGLT-2 Inhibitors Show Durability in Glycemic Control, Weight-Loss Maintenance
Wayne Kuznar
Read More
Pooled Analysis Confirms CV Benefits of DPP-4 Inhibition
Mary Mosley
Read More
Adding Linagliptin to Basal Insulin Reduces Hypoglycemia in Older Patients with Type 2 Diabetes
Mary Mosley
Read More
Novel Predictors of Outcomes in Diabetes
Mary Mosley
Read More
Reductions in HbA1c Levels, Hypoglycemia, and Weight with Linagliptin in Patients with Type 2 Diabetes and Renal Impairment
Mary Mosley
Read More
Lifestyle Intervention Beneficial in Patients with Diabetes, but Not for CV Parameters
Mary Mosley
Read More
1
2
Page 2 of 2
Results 11 - 19 of 19